Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018). Vagus Nerve as Modulator of the Brain–
Gut Axis in Psychiatric and Inflammatory Disorders. Frontiers in Psychiatry, 9, 44.
https://doi.org/10.3389/fpsyt.2018.00044
Collins, L. M., Toulouse, A., Connor, T. J., & Nolan, Y. M. (2012). Contributions of central and
systemic inflammation to the pathophysiology of Parkinson’s disease. Neuropharmacology,
62(7), 2154–2168. https://doi.org/10.1016/j.neuropharm.2012.01.028
Cryan, J. F., O’Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M.,
Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., Guzzetta, K. E., Jaggar, M., LongSmith, C. M., Lyte, J. M., Martin, J. A., Molinero-Perez, A., Moloney, G., Morelli, E., Morillas,
E., … Dinan, T. G. (2019). The Microbiota-Gut-Brain Axis. Physiological Reviews, 99(4),
1877–2013. https://doi.org/10.1152/physrev.00018.2018
De Vadder, F., Grasset, E., Mannerås Holm, L., Karsenty, G., Macpherson, A. J., Olofsson, L. E., &
Bäckhed, F. (2018). Gut microbiota regulates maturation of the adult enteric nervous system via
enteric serotonin networks. Proceedings of the National Academy of Sciences, 115(25),
6458–6463. https://doi.org/10.1073/pnas.1720017115
Dinan, T. G., & Cryan, J. F. (2017). Gut instincts: Microbiota as a key regulator of brain development,
ageing and neurodegeneration: Microbiota-gut-brain axis across the lifespan. The Journal of
Physiology, 595(2), 489–503. https://doi.org/10.1113/JP273106
Doifode, T., Giridharan, V. V., Generoso, J. S., Bhatti, G., Collodel, A., Schulz, P. E., Forlenza, O. V.,
& Barichello, T. (2021). The impact of the microbiota-gut-brain axis on Alzheimer’s disease
pathophysiology. Pharmacological Research, 164, 105314. https://doi.org/10.1016
/j.phrs.2020.105314
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul,
H., Mahlakoiv, T., Jakobshagen, K., Buch, T., Schwierzeck, V., Utermöhlen, O., Chun, E.,
Garrett, W. S., McCoy, K. D., Diefenbach, A., Staeheli, P., Stecher, B., Amit, I., & Prinz, M.
(2015). Host microbiota constantly control maturation and function of microglia in the CNS.
Nature Neuroscience, 18(7), 965–977. https://doi.org/10.1038/nn.4030
Fonseca Cabral, G., Schaan, A. P., Cavalcante, G. C., Sena-dos-Santos, C., de Souza, T. P., Souza
Port’s, N. M., dos Santos Pinheiro, J. A., Ribeiro-dos-Santos, Â., & Vidal, A. F. (2021). Nuclear
and Mitochondrial Genome, Epigenome and Gut Microbiome: Emerging Molecular Biomarkers
for Parkinson’s Disease. International Journal of Molecular Sciences, 22(18), 9839.
https://doi.org/10.3390/ijms22189839
Galland, L. (2014). The Gut Microbiome and the Brain. Journal of Medicinal Food, 17(12),
1261–1272. https://doi.org/10.1089/jmf.2014.7000
Grover, M., & Kashyap, P. C. (2014). Germ-free mice as a model to study effect of gut microbiota on
host physiology. Neurogastroenterology & Motility, 26(6), 745–748. https://doi.org/10.1111
/nmo.12366
Guo, C., Huo, Y.-J., Li, Y., Han, Y., & Zhou, D. (2022). Gut-brain axis: Focus on gut metabolites
short-chain fatty acids. World Journal of Clinical Cases, 10(6), 1754–1763. https://doi.org
/10.12998/wjcc.v10.i6.1754
Kametani, F., & Hasegawa, M. (2018a). Reconsideration of Amyloid Hypothesis and Tau Hypothesis
in Alzheimer’s Disease. Frontiers in Neuroscience, 12, 25. https://doi.org/10.3389
/fnins.2018.00025
Kametani, F., & Hasegawa, M. (2018b). Reconsideration of Amyloid Hypothesis and Tau Hypothesis
in Alzheimer’s Disease. Frontiers in Neuroscience, 12, 25. https://doi.org/10.3389
/fnins.2018.00025
Kaur, H., Nagamoto-Combs, K., Golovko, S., Golovko, M. Y., Klug, M. G., & Combs, C. K. (2020).
Probiotics ameliorate intestinal pathophysiology in a mouse model of Alzheimer’s disease.
Neurobiology of Aging, 92, 114–134. https://doi.org/10.1016/j.neurobiolaging.2020.04.009
Kesika, P., Suganthy, N., Sivamaruthi, B. S., & Chaiyasut, C. (2021). Role of gut-brain axis, gut
microbial composition, and probiotic intervention in Alzheimer’s disease. Life Sciences, 264,
118627. https://doi.org/10.1016/j.lfs.2020.118627
Kowalski, K., & Mulak, A. (2019). Brain-Gut-Microbiota Axis in Alzheimer’s Disease. Journal of
Neurogastroenterology and Motility, 25(1), 48–60. https://doi.org/10.5056/jnm18087
Kurkinen, M. (2021). Alzheimer’s trials: A cul-de-sac with no end in sight. Advances in Clinical and
Experimental Medicine, 30(7), 653–654. https://doi.org/10.17219/acem/139501
Leng, F., & Edison, P. (2021). Neuroinflammation and microglial activation in Alzheimer disease:
Where do we go from here? Nature Reviews Neurology, 17(3), 157–172. https://doi.org/10.1038
/s41582-020-00435-y
Li, Z., Zhu, H., Guo, Y., Du, X., & Qin, C. (2020). Gut microbiota regulate cognitive deficits and
amyloid deposition in a model of Alzheimer’s disease. Journal of Neurochemistry, 155(4),
448–461. https://doi.org/10.1111/jnc.15031
Liu, S., Gao, J., Liu, K., & Zhang, H.-L. (2021). Microbiota-gut-brain axis and Alzheimer’s disease:
Implications of the blood-brain barrier as an intervention target. Mechanisms of Ageing and
Development, 199, 111560. https://doi.org/10.1016/j.mad.2021.111560
McVey Neufeld, K. A., Mao, Y. K., Bienenstock, J., Foster, J. A., & Kunze, W. A. (2013). The
microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the
mouse: Microbiome essential for enteric nervous system. Neurogastroenterology & Motility,
25(2), 183-e88. https://doi.org/10.1111/nmo.12049
Megur, A., Baltriukienė, D., Bukelskienė, V., & Burokas, A. (2020). The Microbiota–Gut–Brain Axis
and Alzheimer’s Disease: Neuroinflammation Is to Blame? Nutrients, 13(1), 37. https://doi.org
/10.3390/nu13010037
Meier-Stephenson, F. S., Meier-Stephenson, V. C., Carter, M. D., Meek, A. R., Wang, Y., Pan, L.,
Chen, Q., Jacobo, S., Wu, F., Lu, E., Simms, G. A., Fisher, L., McGrath, A. J., Fermo, V.,
Barden, C. J., Clair, H. D. S., Galloway, T. N., Yadav, A., Campágna-Slater, V., … Weaver, D. F.
(2022). Alzheimer’s disease as an autoimmune disorder of innate immunity endogenously
modulated by tryptophan metabolites. Alzheimer’s & Dementia: Translational Research &
Clinical Interventions, 8(1). https://doi.org/10.1002/trc2.12283
Muralidar, S., Ambi, S. V., Sekaran, S., Thirumalai, D., & Palaniappan, B. (2020). Role of tau protein
in Alzheimer’s disease: The prime pathological player. International Journal of Biological
Macromolecules, 163, 1599–1617. https://doi.org/10.1016/j.ijbiomac.2020.07.327
Nho, K., Kueider-Paisley, A., MahmoudianDehkordi, S., Arnold, M., Risacher, S. L., Louie, G.,
Blach, C., Baillie, R., Han, X., Kastenmüller, G., Jia, W., Xie, G., Ahmad, S., Hankemeier, T.,
Duijn, C. M., Trojanowski, J. Q., Shaw, L. M., Weiner, M. W., Doraiswamy, P. M., … for the
Alzheimer’s Disease Neuroimaging Initiative and the Alzheimer Disease Metabolomics
Consortium. (2019). Altered bile acid profile in mild cognitive impairment and Alzheimer’s
disease: Relationship to neuroimaging and CSF biomarkers. Alzheimer’s & Dementia, 15(2),
232–244. https://doi.org/10.1016/j.jalz.2018.08.012
Nogal, A., Valdes, A. M., & Menni, C. (2021). The role of short-chain fatty acids in the interplay
between gut microbiota and diet in cardio-metabolic health. Gut Microbes, 13(1), 1–24.
https://doi.org/10.1080/19490976.2021.1897212
Petrella, C., Strimpakos, G., Torcinaro, A., Middei, S., Ricci, V., Gargari, G., Mora, D., De Santa, F.,
& Farioli-Vecchioli, S. (2021). Proneurogenic and neuroprotective effect of a multi strain
probiotic mixture in a mouse model of acute inflammation: Involvement of the gut-brain axis.
Pharmacological Research, 172, 105795. https://doi.org/10.1016/j.phrs.2021.105795
Rezaei Asl, Z., Sepehri, G., & Salami, M. (2019). Probiotic treatment improves the impaired spatial
cognitive performance and restores synaptic plasticity in an animal model of Alzheimer’s
disease. Behavioural Brain Research, 376, 112183. https://doi.org/10.1016/j.bbr.2019.112183
Scardaci, R., Varese, F., Manfredi, M., Marengo, E., Mazzoli, R., & Pessione, E. (2021). Enterococcus
faecium NCIMB10415 responds to norepinephrine by altering protein profiles and phenotypic
characters. Journal of Proteomics, 231, 104003. https://doi.org/10.1016/j.jprot.2020.104003
Sun, J., Xu, J., Ling, Y., Wang, F., Gong, T., Yang, C., Ye, S., Ye, K., Wei, D., Song, Z., Chen, D., &
Liu, J. (2019). Fecal microbiota transplantation alleviated Alzheimer’s disease-like pathogenesis
in APP/PS1 transgenic mice. Translational Psychiatry, 9(1), 189. https://doi.org/10.1038
/s41398-019-0525-3
Wang, X., Sun, G., Feng, T., Zhang, J., Huang, X., Wang, T., Xie, Z., Chu, X., Yang, J., Wang, H.,
Chang, S., Gong, Y., Ruan, L., Zhang, G., Yan, S., Lian, W., Du, C., Yang, D., Zhang, Q., …
Geng, M. (2019). Sodium oligomannate therapeutically remodels gut microbiota and suppresses
gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression.
Cell Research, 29(10), 787–803. https://doi.org/10.1038/s41422-019-0216-x
Wu, M.-L., Yang, X.-Q., Xue, L., Duan, W., & Du, J.-R. (2021). Age-related cognitive decline is
associated with microbiota-gut-brain axis disorders and neuroinflammation in mice. Behavioural
Brain Research, 402, 113125. https://doi.org/10.1016/j.bbr.2021.113125
Xu, H.-M., Huang, H.-L., Zhou, Y.-L., Zhao, H.-L., Xu, J., Shou, D.-W., Liu, Y.-D., Zhou, Y.-J., &
Nie, Y.-Q. (2021). Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut
to the Brain. Gastroenterology Research and Practice, 2021, 1–20. https://doi.org/10.1155
/2021/6699268
Zhou, Y., Wang, Y., Quan, M., Zhao, H., & Jia, J. (2021). Gut Microbiota Changes and Their
Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer’s Disease. Journal of
Alzheimer’s Disease, 81(2), 583–595. https://doi.org/10.3233/JAD-201497